Dossier assessment

Vibegron (overactive bladder) – Benefit assessment according to §35a Social Code Book V

Status
Status: Commission completed
Project no.
A25-39
Last updated

Report documents

  1. Extract of dossier assessment

    Vibegron (overactive bladder) – Benefit assessment according to §35a Social Code Book V

    published on
    Document type
    PDF document, 744 kB, EN, not accessible
    DOI-Link
    https://doi.org/10.60584/A25-39_en
  2. Dossier assessment

    Vibegron (overactive bladder) – Benefit assessment according to §35a Social Code Book V

    published on
    Document type
    PDF document, 1 MB, DE, not accessible
    DOI-Link
    https://doi.org/10.60584/A25-39

Dossier assessment

Indication:

Symptomatic treatment of adult patients with overactive bladder (OAB) syndrome

Result of dossier assessment:
  • Patients ≥ 65 years: hint of a minor added benefit
  • Patients < 65 years: added benefit not proven

Project details

Project no.
A25-39
Commission
Commission awarded on 03.03.2025 by the Federal Joint Committee (GBA).
Report type
Dossier assessment
Status
Commission completed
Department/Division
Drug Assessment
Topic
Kidneys and urinary system
Note

After completion of the assessment by IQWiG the Federal Joint Committee (GBA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the GBA website.

DOI

https://doi.org/10.60584/A25-39

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form